根据美国证券交易委员会（SEC）最新文件披露，Apimeds Pharmaceuticals US Inc（简称APUS）已正式宣布两项关键人事任命：赵先生（Mr. Cho）出任公司首席执行官（CEO），余先生（Mr. Yu）担任公司秘书（Secretary）。两项任命均自公告之日起立即生效。
此次高层变动标志着APUS在战略执行和公司治理方面迈出重要一步。新任CEO赵先生将全面负责公司的整体运营及业务发展方向，而余先生作为秘书，将协助强化公司合规管理与信息披露事务。
公司未在文件中进一步披露两位高管的详细背景或具体职责划分。市场关注此次人事调整是否将为Apimeds Pharmaceuticals US Inc带来新的发展策略或业务重组。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.